Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Assets (2021 - 2025)

HCW Biologics (HCWB) has disclosed Return on Assets for 5 consecutive years, with 0.47% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets rose 94.0% year-over-year to 0.47%, compared with a TTM value of 0.47% through Sep 2025, up 94.0%, and an annual FY2024 reading of 1.03%, down 33.0% over the prior year.
  • Return on Assets was 0.47% for Q3 2025 at HCW Biologics, up from 0.48% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.23% in Q1 2022 and bottomed at 1.4% in Q3 2024.
  • Average Return on Assets over 5 years is 0.61%, with a median of 0.48% recorded in 2025.
  • The sharpest move saw Return on Assets crashed -87bps in 2024, then skyrocketed 94bps in 2025.
  • Year by year, Return on Assets stood at 0.24% in 2021, then decreased by -27bps to 0.31% in 2022, then plummeted by -162bps to 0.81% in 2023, then tumbled by -31bps to 1.06% in 2024, then skyrocketed by 56bps to 0.47% in 2025.
  • Business Quant data shows Return on Assets for HCWB at 0.47% in Q3 2025, 0.48% in Q2 2025, and 0.88% in Q1 2025.